Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer

This publication has 14 references indexed in Scilit:

• The Importance of Surgery to Non-Small Cell Carcinoma of Lung with Mediastinal Lymph Node Metastasis
  The Annals of Thoracic Surgery, 1988
• Preoperative combined modality therapy for stage III M0 non-small cell lung carcinoma
  International Journal of Radiation Oncology*Biology*Physics, 1988
• Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinoma
  European Journal of Cancer and Clinical Oncology, 1988
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
  Journal of Clinical Oncology, 1988
• The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0)
  The Annals of Thoracic Surgery, 1988
• Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer.From the Manchester Lung Tumour Group
  Cancer, 1988
• The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group.
  Journal of Clinical Oncology, 1988
• Results of Resection in Non-Oat Cell Carcinoma of the Lung with Mediastinal Lymph Node Metastases
  Annals of Surgery, 1983
• An aggressive approach to marginally resectable lung cancer
  Cancer, 1978
• Ifosfamide in the treatment of recurrent or disseminated lung cancerA phase II study of two dose schedules
  Cancer, 1978